Click Therapeutics has won the first-ever FDA approval for a treatment for the negative symptoms of schizophrenia – a digital ...
The possibilities of recovery and the search for treatments are the subjects of an enormous amount of research, and a wide ...
In this discussion, Heather Burrell-Ward, M.D., provides an overview of her recent study that found TMS aimed at the default mode network improved processing speed in schizophrenia.
Click Therapeutics has nabbed FDA approval for its digital therapeutic Motivista, which now becomes the first authorized ...
The FDA has cleared Motivista, the first prescription digital therapeutic indicated to treat negative symptoms of ...
Motivista is a prescription digital therapeutic indicated for the treatment of negative symptoms of schizophrenia as an ...
Individuals with first-episode schizophrenia experience varying degrees of cognitive impairment that can be categorized into 2 distinct subtypes.
Chennai, Oct. 5 -- Highlights: ...
In medicine, schizophrenia is treated as a single diagnostic entity. However, even among people diagnosed with the same ...
The petitioner was a CRPF employee who retired on medical invalidation grounds in 1999 after he was found to have ...
Billy Lumby's feature directorial debut, about severe mental health conditions, has its world premiere at the San Sebastian ...